ArticleOncoimmunology2022

Mycobacterial surface characters remodeled by growth conditions drive different tumor-infiltrating cells and systemic IFN-γ/IL-17 release in bladder cancer treatment.

Sandra Guallar-Garrido et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.